ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss

June 5, 1981

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

In Brief: Resolution wasn’t Strong Enough, Reizen Though; Two More chemicals reported Out of Bioassay

June 3, 1977

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975

Prevention Facility For Intramural Research Approved, Also Would Involve Academic Investigators

November 1, 1991

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007